DEFITELIO is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Defibrotide Sodium.
| Product ID | 68727-800_0173efe0-e4e2-41f6-b044-81f707120906 | 
| NDC | 68727-800 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | DEFITELIO | 
| Generic Name | Defibrotide Sodium | 
| Dosage Form | Injection, Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2016-03-30 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA208114 | 
| Labeler Name | Jazz Pharmaceuticals, Inc. | 
| Substance Name | DEFIBROTIDE SODIUM | 
| Active Ingredient Strength | 80 mg/mL | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2016-03-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA208114 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2016-03-30 | 
| Marketing Category | NDA | 
| Application Number | NDA208114 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2016-03-30 | 
| Ingredient | Strength | 
|---|---|
| DEFIBROTIDE SODIUM | 80 mg/mL | 
| SPL SET ID: | 2c3db989-d7ad-41ed-9ebf-698dcf6c24ec | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  DEFITELIO  87638258  5652544 Live/Registered | Gentium S.r.l. 2017-10-09 | 
|  DEFITELIO  87034509  5487126 Live/Registered | Gentium S.r.l. 2016-05-12 | 
|  DEFITELIO  79099301  4162914 Live/Registered | Gentium S.r.l. 2011-05-16 |